Skip to main content
SpringerLink
Log in

Metaanalyses—highest level of empirical evidence?

  • EDITORIAL
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Anderson IM (1998) SSRIs versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety 7(Suppl 1):11–17

    Article  PubMed  Google Scholar 

  2. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19–36

    Article  PubMed  CAS  Google Scholar 

  3. Feinstein AR (1995) Meta-analysis: statistical alchemy for the 21st century. J Clin Epidemiol 48:71–79

    PubMed  CAS  Google Scholar 

  4. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330:396–402

    PubMed  CAS  Google Scholar 

  5. Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321:1371–1376

    Article  PubMed  CAS  Google Scholar 

  6. Geddes JR, Harrison P, Freemantle N (2003) New generation versus conventional antipsychotics. Lancet 362:404

    Article  PubMed  Google Scholar 

  7. Gunnell D, Saperia J, Ashby D (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA’s safety review. BMJ 330:385–389

    PubMed  CAS  Google Scholar 

  8. Jüni P, Altman DG, Egger M (2001) Assessing the quality of controlled clinical trials. BMJ 323:42–46

    PubMed  Google Scholar 

  9. Leucht S, Wahlbeck K, Hamann J, Kissling W (2003) New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361:1581–1589

    Article  PubMed  CAS  Google Scholar 

  10. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326:1171–1173

    Article  PubMed  Google Scholar 

  11. Sterne JA, Gavaghan DJ, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53:1119–1129

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Direktor der Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany

    Wolfgang Maier

  2. Psychiatrische Klinik der Ludwig-Maximilians-Universität München, Nussbaumstrasse 7, 80336, München, Germany

    Hans-Jürgen Möller

Authors
  1. Wolfgang Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans-Jürgen Möller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maier, W., Möller, HJ. Metaanalyses—highest level of empirical evidence?. Eur Arch Psychiatry Clin Neurosci 255, 369–370 (2005). https://doi.org/10.1007/s00406-005-0607-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-005-0607-5

Keywords

Search

Navigation